Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Oct 22 · inside the Ichimoku cloud · RSI 45 · MACD below its signal
| 0.0360 | 52-week high | +275.00% |
| 0.0200 | Previous week high | +108.33% |
| 0.0110 | Previous month high | +14.58% |
| 0.009600 | R3 (classic) | +0.00% |
| 0.009600 | R2 (classic) | +0.00% |
| 0.009600 | R1 (classic) | +0.00% |
| 0.009600 | Pivot | +0.00% |
| 0.009600 | S1 (classic) | +0.00% |
| 0.009600 | S2 (classic) | +0.00% |
| 0.009600 | S3 (classic) | +0.00% |
| 0.009600 | Previous day high | +0.00% |
| 0.009600 | Previous day low | +0.00% |
| 0.009600 | Price now | |
| 0.007000 | Previous week low | −27.08% |
| 0.007000 | Previous month low | −27.08% |
| 0.006000 | 52-week low | −37.50% |
None of the 29 investors followed here reported a position in NASC in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NASC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for NASC.
TimeframesDown on the monthly, mixed on the hourly, daily and weekly.
pulling back under the 21 EMA
pulling back under the 21 EMA
under a flat 21 EMA
under a falling 21 EMA, 21 under 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 62.5 | -42.3 | -20.0 | 33.3 | -18.8 | 23.1 | -6.3 | -46.7 | 12.5 | 6.7 | −40.0% | ||
| 2025 | 0.0 | 38.9 | 30.0 | -40.0 | -38.5 | -33.3 | 31.2 | -4.8 | 5.0 | -14.3 | 11.1 | -20.0 | −55.6% |
| 2024 | 14.8 | 67.7 | -36.5 | 15.2 | -57.9 | -6.3 | 20.0 | -38.9 | 18.2 | 184.6 | 35.1 | -28.0 | +33.3% |
| 2023 | -19.2 | -40.0 | 34.9 | -23.8 | -15.1 | -60.0 | -56.8 | 16.8 | -34.2 | -52.1 | 100.0 | -61.4 | −97.9% |
| 2022 | 6.0 | -35.2 | 7.8 | -0.9 | -18.2 | 0.0 | 33.3 | -49.2 | -1.6 | -33.7 | -5.8 | -30.7 | −82.7% |
| 2021 | -11.5 | 2.6 | -20.3 | 4.3 | -18.0 | 14.4 | 47.8 | 0.0 | -0.7 | -9.6 | -19.7 | 2.0 | −23.1% |
| 2020 | 15.4 | -26.7 | -60.3 | -42.7 | 33.3 | 97.5 | -54.4 | -31.1 | -6.5 | -36.2 | 21.6 | 44.4 | −83.3% |
| 2019 | 19.5 | -43.9 | -20.0 | 40.9 | -38.7 | 2.6 | -25.6 | -10.3 | -19.2 | -9.5 | -21.1 | -13.3 | −84.1% |
| 2018 | -20.6 | 66.7 | -42.2 | -23.1 | -10.0 | 22.2 | -40.9 | 438.5 | -47.1 | 0.0 | 13.5 | 95.2 | +141.2% |
| 2017 | 72.4 | -42.0 | -27.6 | 0.0 | 33.3 | -10.7 | -60.0 | 80.0 | -50.0 | -11.1 | 50.0 | 183.3 | +17.2% |
| 2016 | 6.4 | -35.3 | 9.3 | -20.7 | 6.2 | -42.0 | 55.0 | 27.4 | -16.5 | -16.7 | -43.6 | -6.5 | −73.4% |
| 2015 | 18.2 | 7.7 | 14.3 | 0.0 | -36.3 | -2.0 | 500.0 | -20.0 | -41.7 | 21.4 | -11.8 | -27.3 | +98.2% |
| 2014 | 171.4 | -23.2 | 20.5 | -18.2 | -16.7 | -50.0 | 0.0 | 166.7 | -25.0 | -16.7 | 0.0 | 10.0 | +57.1% |
| 2013 | 47.6 | -9.7 | 0.0 | -28.6 | 5.0 | -33.3 | -0.7 | -35.3 | -64.4 | 37.5 | 61.4 | -50.7 | −83.3% |
| 2012 | -34.2 | -20.0 | -30.0 | 50.0 | −44.7% |
No analyst coverage for this instrument.
Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.
No recent headlines.